发明授权
US08003651B2 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors 有权
嘧啶环戊烷作为AKT蛋白激酶抑制剂

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
摘要:
The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
公开/授权文献
信息查询
0/0